Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria Furer

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Mayo Clinic Proceedings|August 6, 2022
Twenty Years of Targeted and Biologic Immunomodulatory Drugs: Postmarketing Modifications of Drug Labels Approved by the US Food and Drug AdministrationJulia Berman, Yarden Yavne, Yonatan Edel, et al.
Rheumatology (Oxford, England)|May 19, 2025
Association of clinical and sonographic factors with discrepancy between patients' and evaluators' global assessments in psoriatic arthritisKatya Meridor, Victoria Furer, Tzipora Shochat, et al.
Immunological Investigations|August 24, 2023
Circulating and Synovial Monocytes in Arthritis and Ex-Vivo Model to Evaluate Therapeutic Modulation of Synovial MonocytesAdam Slavick, Victoria Furer, Ari Polachek, et al.
Rheumatology (Oxford, England)|April 13, 2021
Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case seriesVictoria Furer, Devy Zisman, Adi Kibari, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2010
The role of microRNA in rheumatoid arthritis and other autoimmune diseasesVictoria Furer, Jeffrey D Greenberg, Mukundan Attur, et al.
Arthritis Care & Research|April 13, 2011
RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegolTheodore Pincus, Victoria Furer, Edward Keystone, et al.
Biologics : Targets & Therapy|November 25, 2021
Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant PopulationJulia Berman, Victoria Furer, Mark Berman, et al.
Clinical and Experimental Rheumatology|April 22, 2021
Relationship between religiosity, spirituality and physical and mental outcomes in fibromyalgia patientsValerie Aloush, Anna Gurevich-Shapiro, Eyal Hazan, et al.
Molecular and Cellular Neurosciences|December 11, 2003
Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cellsTamir Ben-Hur, Ofra Ben-Menachem, Victoria Furer, et al.
Seminars in Arthritis and Rheumatism|October 18, 2011
Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imagingVictoria Furer, Zahi A Fayad, Venkatesh Mani, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Mayo Clinic Proceedings|August 6, 2022
Twenty Years of Targeted and Biologic Immunomodulatory Drugs: Postmarketing Modifications of Drug Labels Approved by the US Food and Drug AdministrationJulia Berman, Yarden Yavne, Yonatan Edel, et al.
Rheumatology (Oxford, England)|May 19, 2025
Association of clinical and sonographic factors with discrepancy between patients' and evaluators' global assessments in psoriatic arthritisKatya Meridor, Victoria Furer, Tzipora Shochat, et al.
Immunological Investigations|August 24, 2023
Circulating and Synovial Monocytes in Arthritis and Ex-Vivo Model to Evaluate Therapeutic Modulation of Synovial MonocytesAdam Slavick, Victoria Furer, Ari Polachek, et al.
Rheumatology (Oxford, England)|April 13, 2021
Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case seriesVictoria Furer, Devy Zisman, Adi Kibari, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2010
The role of microRNA in rheumatoid arthritis and other autoimmune diseasesVictoria Furer, Jeffrey D Greenberg, Mukundan Attur, et al.
Arthritis Care & Research|April 13, 2011
RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegolTheodore Pincus, Victoria Furer, Edward Keystone, et al.
Biologics : Targets & Therapy|November 25, 2021
Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant PopulationJulia Berman, Victoria Furer, Mark Berman, et al.
Clinical and Experimental Rheumatology|April 22, 2021
Relationship between religiosity, spirituality and physical and mental outcomes in fibromyalgia patientsValerie Aloush, Anna Gurevich-Shapiro, Eyal Hazan, et al.
Molecular and Cellular Neurosciences|December 11, 2003
Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cellsTamir Ben-Hur, Ofra Ben-Menachem, Victoria Furer, et al.
Seminars in Arthritis and Rheumatism|October 18, 2011
Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imagingVictoria Furer, Zahi A Fayad, Venkatesh Mani, et al.
Pageof 8